PNPO and bladder transitional cell carcinoma: For PFI, the overexpressed mRNA level of PNPO represented an adverse factor in BLCA (p = 0.038), while the overexpressed PNPO was a favorable factor in KIRC (p = 0.004) (Supplementary Table S2).